Top Analyst Upgrades and Downgrades: Biogen, Exxon, MarkWest, Yum! and More

Photo of Jon C. Ogg
By Jon C. Ogg Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Stocks are again challenging news high, and earnings season has all but ended. Investors still worry about buying the top and about the next major market correction. 24/7 Wall St. looks over dozens of analyst research reports each morning, on the hunt for new ideas for its readers. Some are stocks to buy, others are stocks to sell. These are this Thursday’s top analyst upgrades, downgrades and initiations seen from Wall Street research firms.

Biogen Idec Inc. (NASDAQ: BIIB) was raised to Outperform from Market Perform with a $422 price target (versus a $339 close and a $353.47 all-time high) at BMO Capital Markets.

Exxon Mobil Corp. (NYSE: XOM) was maintained Neutral and the earnings estimates were lowered due to full valuations after the company’s 2014 drilling and capex targets by Credit Suisse. Merrill Lynch is simply maintaining its Neutral rating because any catalyst for a near-term rebound was likely pushed out until growth restarts in 2015.

MarkWest Energy Partners L.P. (NYSE: MWE) was downgraded to Neutral from Overweight at J.P. Morgan. Keep in mind that this master limited partnership was downgraded at RBC Capital Markets, Wells Fargo and Morgan Stanley within the past week or so.

Yum! Brands Inc. (NYSE: YUM) was raised to Outperform from Neutral with an $87 price target (versus a $74.81 close), based on a China recovery after the 2013 problems, at R.W. Baird. The firm even is calling for 10% earnings growth as sustainable due to emerging market expansion.

Other Key Analyst Calls

Anadarko Petroleum Corp. (NYSE: APC) was raised to Buy with price target of $96 at Argus.

Axiall Corp. (NYSE: AXLL) was raised to Buy from Neutral and the price target was raised to $60 from $45 (versus a $42.04 close) at Goldman Sachs.

Consolidated Edison Inc. (NYSE: ED) was raised to Buy with a price target of $60, based on valuation and dividend yield at Argus.

Emeritus Corp. (NYSE: ESC) was downgraded to Hold from Buy at Deutsche Bank.

Jones Lang LaSalle Inc. (NYSE: JLL) was resumed with a Buy rating and $149 price target (versus a $122.63 close) by Goldman Sachs.

Karyopharm Therapeutics Inc. (NASDAQ: KPTI) was reiterated as Buy and the price target was raised to $48 from $40 at Merrill Lynch, based on the potential use in solid tumors and significant catalysts in 2014.

Qualcomm Inc. (NASDAQ: QCOM) was reiterated as Buy with an $82 price target (versus a $76.67 close) with raised earnings estimates at Sterne Agee. Argus also maintained its Buy rating after the buyback and dividend news.

Spark Networks Inc. (NYSE: LOV) was downgraded to Hold from Buy and the price target was cut to $6 from $10 (versus a $5.75 close) at Canaccord Genuity. The firm said that the fourth-quarter report portends a temporary pause in growth.

Tiffany & Co. (NYSE: TIF) was raised to Buy from Neutral at Citigroup.

Photo of Jon C. Ogg
About the Author Jon C. Ogg →

Jon Ogg has been a financial news analyst since 1997. Mr. Ogg set up one of the first audio squawk box services for traders called TTN, which he sold in 2003. He has previously worked as a licensed broker to some of the top U.S. and E.U. financial institutions, managed capital, and has raised private capital at the seed and venture stage. He has lived in Copenhagen, Denmark, as well as New York and Chicago, and he now lives in Houston, Texas. Jon received a Bachelor of Business Administration in finance at University of Houston in 1992. a673b.bigscoots-temp.com.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618